Epinephrine

A study involving an oral allergen challenge revealed promising results for a sublingual epinephrine strip, a delivery method that is being evaluated as an alternative to epinephrine autoinjectors.

Healio has compiled November’s most read news in asthma and allergy.

Allergen-related symptoms resolved within 5 minutes after an oral allergen challenge with the Anaphylm sublingual epinephrine strip from Aquestive Therapeutics, according to a press release from the company.

A retrospective chart review revealed a 50% increase in outpatient pediatric psychology referrals from the Food Allergy Treatment Center between 2013 and 2023.

Epinephrine autoinjectors may be associated with short-lived peak plasma levels, unpredictable cardiovascular responses as well as varying epinephrine absorption, according to a review published in Clinical and Experimental Allergy.

BOSTON — An intranasal epinephrine powder produced responses that were comparable with intramuscular administration, according to a poster presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

The FDA approved ARS Pharmaceuticals’ neffy epinephrine nasal spray for emergency allergic reactions in children and adults weighing at least 66 pounds.

Our political system ensures that everyone throughout the country has representation, Melinda M. Rathkopf, MD, MBA, told Healio. Leveraging that representation is essential when physicians need to advocate for their patients and themselves.

Advocates were pleased to learn about the FDA’s approval of ARS Pharmaceuticals’ neffy epinephrine nasal spray, which may have a significant impact on the safety and quality of life of families with allergy.

The FDA has approved neffy epinephrine nasal spray for emergency treatment of Type 1 allergic reactions, including anaphylaxis, in pediatric and adult individuals weighing at least 66 pounds.